- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
-
March 10, 2023Robins Kaplan Announces $28 Million Settlement in Case Against For-Profit College’s Directors & Officers
-
March 9, 2023Robins Kaplan LLP Launches New Professional Development Program
-
March 19-22, 2023PLRB 2023 Claims Conference
-
March 29-30, 2023ACI Managed Care Disputes and Litigation
-
April 3, 2023Conference of Tribal Lending Commissioners
-
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
-
February 22, 2023A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
-
February 7, 2023When Monkey Business Slips Into Trademark Infringement
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Eric Lindenfeld Joins Robins Kaplan's Mass Tort Group
March 24, 2017
Robins Kaplan LLP recently welcomed Eric Lindenfeld to the firm’s Mass Tort Group, where he focuses his practice on representing individuals who have been harmed by defective pharmaceutical and medical device products. Lindenfeld has experience in all phases of mass tort litigation, including trial practice, motion practice, conducting depositions, and written discovery. He is admitted to practice in Minnesota and in the U.S. District Court, District of Minnesota.
Lindenfeld earned his law degree, with honors, from the University of Minnesota. While attending law school, he won awards for outstanding written advocacy in various moot court competitions. He has also authored several scholarly articles on cutting-edge and developing topics in mass tort litigation.
Lindenfeld’s publications have been widely cited by law professors and practitioners, including in the Law, Medicine & Medical Technology and the Food and Drug Administration casebooks.
Related Professionals
Eric M. Lindenfeld
Associate
Related Publications
Related News
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.